Scott D. Patterson

20.3k total citations · 2 hit papers
219 papers, 11.0k citations indexed

About

Scott D. Patterson is a scholar working on Molecular Biology, Epidemiology and Spectroscopy. According to data from OpenAlex, Scott D. Patterson has authored 219 papers receiving a total of 11.0k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Molecular Biology, 43 papers in Epidemiology and 41 papers in Spectroscopy. Recurrent topics in Scott D. Patterson's work include Advanced Proteomics Techniques and Applications (37 papers), Pneumonia and Respiratory Infections (33 papers) and Statistical Methods in Clinical Trials (29 papers). Scott D. Patterson is often cited by papers focused on Advanced Proteomics Techniques and Applications (37 papers), Pneumonia and Respiratory Infections (33 papers) and Statistical Methods in Clinical Trials (29 papers). Scott D. Patterson collaborates with scholars based in United States, United Kingdom and Germany. Scott D. Patterson's co-authors include Ruedi H. Aebersold, Eric Van Cutsem, Marc Peeters, Salvatore Siena, Todd Juan, Sid Suggs, Michael Wolf, Daniel J. Freeman, Ruedi Aebersold and Rafael G. Amado and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Scott D. Patterson

213 papers receiving 10.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer

2008 2.4k citations Rafael G. Amado, Michael Wolf et al. Journal of Clinical Oncology profile →
The C-terminal domain of RNA polymerase II couples mRNA processing to transcription

1997 747 citations Scott D. Patterson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott D. Patterson United States	47	4.9k	3.0k	2.0k	1.5k	1.1k	219	11.0k
David E. Misek United States	53	7.1k 1.4×	2.0k 0.7×	1.4k 0.7×	560 0.4×	1.0k 0.9×	95	11.1k
Shu Zheng China	53	6.1k 1.2×	3.0k 1.0×	398 0.2×	785 0.5×	1.4k 1.2×	370	11.2k
Elise C. Kohn United States	69	11.7k 2.4×	6.8k 2.3×	2.4k 1.2×	679 0.5×	1.9k 1.7×	327	21.1k
Daniel W. Chan United States	50	4.1k 0.8×	1.1k 0.4×	2.0k 1.0×	586 0.4×	2.6k 2.3×	161	9.4k
Graeme I. Murray United Kingdom	58	5.5k 1.1×	4.4k 1.5×	332 0.2×	891 0.6×	1.2k 1.0×	197	12.0k
David A. Fishman United States	53	6.3k 1.3×	2.2k 0.7×	2.2k 1.1×	346 0.2×	566 0.5×	157	11.4k
Ross S. Berkowitz United States	66	4.6k 0.9×	2.7k 0.9×	374 0.2×	1.0k 0.7×	1.0k 0.9×	445	18.7k
Emanuel F. Petricoin United States	51	6.7k 1.4×	1.5k 0.5×	2.3k 1.1×	365 0.2×	620 0.5×	195	9.5k
Martin McIntosh United States	49	3.7k 0.8×	1.5k 0.5×	1.8k 0.9×	430 0.3×	599 0.5×	112	8.0k
Sudhir Srivastava United States	41	3.4k 0.7×	3.6k 1.2×	366 0.2×	566 0.4×	1.5k 1.3×	142	8.9k

Countries citing papers authored by Scott D. Patterson

Since Specialization

Citations

This map shows the geographic impact of Scott D. Patterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott D. Patterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott D. Patterson more than expected).

Fields of papers citing papers by Scott D. Patterson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott D. Patterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott D. Patterson. The network helps show where Scott D. Patterson may publish in the future.

Co-authorship network of co-authors of Scott D. Patterson

This figure shows the co-authorship network connecting the top 25 collaborators of Scott D. Patterson. A scholar is included among the top collaborators of Scott D. Patterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott D. Patterson. Scott D. Patterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lehn, Alexander, Jee‐Young Lee, Giorgia Sciacca, et al.. (2025). The Management of Parkinson's Disease Before, during and after Pregnancy—an MDS Scientific Issues Committee Review. Movement Disorders Clinical Practice. 13(1). 44–59.

Patterson, Scott D., Louise Shaw, Michelle M. Rank, & Brett Vaughan. (2023). Assessments Used for Summative Purposes during Internal Medicine Specialist Training: A Rapid Review. Education Sciences. 13(10). 1057–1057. 1 indexed citations

Thompson, Allison, Nicola P. Klein, H. Jackson Downey, et al.. (2018). Coadministration of 13-valent pneumococcal conjugate and quadrivalent inactivated influenza vaccines in adults previously immunized with polysaccharide pneumococcal vaccine 23: a randomized clinical trial. Human Vaccines & Immunotherapeutics. 15(2). 444–451. 16 indexed citations

Juergens, Christine, James Trammel, Yasuko Shoji, et al.. (2018). Late onset of injection site reactions after vaccination with the 13-valent pneumococcal conjugate vaccine in adult study populations. Human Vaccines & Immunotherapeutics. 14(8). 1948–1956. 4 indexed citations

Namulanda, Gonza, Judith R. Qualters, A. Vaidyanathan, et al.. (2018). Electronic health record case studies to advance environmental public health tracking. Journal of Biomedical Informatics. 79. 98–104. 12 indexed citations

Lipsitch, Marc, Lucy M. Li, Scott D. Patterson, et al.. (2017). Serotype-specific immune responses to pneumococcal conjugate vaccine among children are significantly correlated by individual: Analysis of randomized controlled trial data. Vaccine. 36(4). 473–478. 12 indexed citations

Peeters, Marc, Kelly S. Oliner, Timothy Price, et al.. (2014). KRAS/NRAS and BRAF Mutations in the 20050181 Study of Panitumumab + FOLFIRI for the 2ND-Line Treatment of Metastatic Colorectal Cancer: Updated Analysis. Annals of Oncology. 25. ii5–ii5. 2 indexed citations

McCaffery, Ian, Yanyan Tudor, Hongjie Deng, et al.. (2013). Putative Predictive Biomarkers of Survival in Patients with Metastatic Pancreatic Adenocarcinoma Treated with Gemcitabine and Ganitumab, an IGF1R Inhibitor. Clinical Cancer Research. 19(15). 4282–4289. 54 indexed citations

Peeters, Marc, Kelly S. Oliner, Alex Parker, et al.. (2013). Massively Parallel Tumor Multigene Sequencing to Evaluate Response to Panitumumab in a Randomized Phase III Study of Metastatic Colorectal Cancer. Clinical Cancer Research. 19(7). 1902–1912. 185 indexed citations

10.

Oliner, Kelly S., Jean‐Yves Douillard, Salvatore Siena, et al.. (2013). Evaluation of KRAS, NRAS, and BRAF Mutations in Prime: Panitumumab with FOLFOX4 as First-Line Treatment in Metastatic Colorectal Cancer (MCRC). Annals of Oncology. 24. iv23–iv24. 2 indexed citations

11.

Chaidos, Aristeidis, Scott D. Patterson, Richard Szydlo, et al.. (2012). Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation. Blood. 119(21). 5030–5036. 120 indexed citations

12.

Kim, Dong Soo, Seon Hee Shin, Hoan Jong Lee, et al.. (2012). Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine Given to Korean Children Receiving Routine Pediatric Vaccines. The Pediatric Infectious Disease Journal. 32(3). 266–273. 18 indexed citations

13.

Galiza, Eva, Daniel A. Scott, Scott D. Patterson, et al.. (2009). Immunogenicity of booster doses of 13-valent pneumococcal conjugate and Hib/MenC vaccines given at 12 months of age in the UK. ePrints Soton (University of Southampton). 9 indexed citations

14.

Anderson, N. Leigh, Norman G. Anderson, Terry W. Pearson, et al.. (2009). A Human Proteome Detection and Quantitation Project. Molecular & Cellular Proteomics. 8(5). 883–886. 149 indexed citations

15.

Amado, Rafael G., Michael Wolf, Marc Peeters, et al.. (2008). Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer. Journal of Clinical Oncology. 26(10). 1626–1634. 2400 indexed citations breakdown →

16.

Patterson, Scott D., Aristeidis Chaidos, David C. A. Neville, et al.. (2008). Human Invariant NKT Cells Display Alloreactivity Instructed by Invariant TCR-CD1d Interaction and Killer Ig Receptors. The Journal of Immunology. 181(5). 3268–3276. 19 indexed citations

17.

Patterson, Scott D. & Robert DuBose. (2006). The role of biomarkers in the future of drug development. Expert Opinion on Drug Discovery. 1(3). 199–204. 1 indexed citations

18.

Patterson, Scott D., Ιoannis Kotsianidis, António Almeida, et al.. (2005). Human Invariant NKT Cells Are Required for Effective In Vitro Alloresponses. The Journal of Immunology. 175(8). 5087–5094. 8 indexed citations

19.

Patterson, Scott D.. (2005). Investigating Drug-Induced QT and QTc Prolongation in the Clinic: A Review of Statistical Design and Analysis Considerations: Report from the Pharmaceutical Research and Manufacturers of America QT Statistics Expert Team. Drug Information Journal. 39(3). 243–265. 52 indexed citations

20.

Bell, K., C. C. Pollitt, & Scott D. Patterson. (1988). Subdivision of equine Tf into H₁ and H₂. Animal Genetics. 19(2). 177–183. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact